2013
DOI: 10.1039/c3lc50246e
|View full text |Cite
|
Sign up to set email alerts
|

Product qualification: a barrier to point-of-care microfluidic-based diagnostics?

Abstract: One of the most exciting applications of microfluidics-based diagnostics is its potential use in next generation point-of-care (POC) devices. Many prototypes are already in existence, but, as of yet, few have achieved commercialisation. In this article, we consider the issue surrounding product qualification as a potential barrier to market success. The study discusses, in the context of POC microfluidics-based diagnostics, what the generic issues are and potential solutions. Our findings underline the need fo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
12
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(12 citation statements)
references
References 15 publications
0
12
0
Order By: Relevance
“…1 illustrates a sealed microfluidic device having fluidic and electrical connections. Typically, after the fabrication of microfluidic structures and electrodes, various back-end processes are needed to realize a fully-functional device [15,16]. Taking the example in Fig.…”
Section: Introductionmentioning
confidence: 99%
“…1 illustrates a sealed microfluidic device having fluidic and electrical connections. Typically, after the fabrication of microfluidic structures and electrodes, various back-end processes are needed to realize a fully-functional device [15,16]. Taking the example in Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Such drawback inhibits the creation of profitable businesses. 17 We address herein a POC platform for performing the Bradford assay using smartphone-based optical detection. The smartphones have been widely used to the development of POC analytical tools for different colorimetric quantitative analyses, including immunoassays, biochemical and healthcare experiments.…”
mentioning
confidence: 99%
“…Several reviews have analyzed the challenges involved in LOC commercialization process, explaining some of the reasons for the delayed spread of devices into mainstream healthcare and highlighting aspects that are necessary for successful commercialization [9][10][11]. First, it is important to address LOC designs as a total analysis system rather than focusing on discrete modules, while still maintaining a clear and specific final analytical goal.…”
Section: Introductionmentioning
confidence: 99%